Keywords: Artemisinin; Histone deacetylase (HDAC) inhibitors; Hydroxamic acids; Endoperoxide; Cytotoxicity;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Histone deacetylase (HDAC) inhibitors; Hydroxamic acids; Isatin; Heterocycle;
Keywords: Histone deacetylase (HDAC) inhibitors; Hydroxamic acids; Isatin; Heterocycle;
Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents
Keywords: Histone deacetylase (HDAC) inhibitors; Hydroxamic acids; Quinazolin-4(3H)-one;
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity
Keywords: Histone deacetylase (HDAC) inhibitors; N-hydroxybenzamides; Hydroxamic acids; 2-oxoindoline; Triazole; Click chemistry;
Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
Keywords: Peripheral T-cell lymphoma (PTCL); Histone deacetylase (HDAC) inhibitors; Pralatrexate; Epigenetic; Antibody drug conjugates;
Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors
Keywords: Histone deacetylase (HDAC) inhibitors; Zn-binding group; Antiproliferative activity; Synthesis;
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
Keywords: DNA methylation; Epigenetics; Histone deacetylase (HDAC) inhibitors; Early life adversity; Alzheimer disease; Schizophrenia; Epilepsy; Valproic acid; S-adenosylmethionine (SAM); Epigenetic therapy;
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: Synthesis and biological evaluation of valproic esters of 3′-C-methyladenosine
Keywords: Histone deacetylase (HDAC) inhibitors; Ribonucleotide reductase (RR) inhibitors; Hematological and solid tumors; Apoptosis; 3′-C-Methyladenosine; Valproic acid
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
Keywords: Romidepsin; Head and neck cancer; Squamous cell carcinoma; Histone deacetylase (HDAC) inhibitors; Phase II trial